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Purpose: Diabetic retinopathy screening involves labour intensive 
manual grading of retinal images. Automated Retinal Image Analysis 
(ARIA) software can determinine whether diabetic retinal disease is 
present as an alternative to human graders. We aim to evaluate the 
clinical effectiveness/ cost-effectiveness of three CE marked ARIA 
softwares in a large number of patient images acquired as part of 
routine diabetic retinopathy screening in a NHS (National Health 
Service) setting in the United Kingdom.
Methods: Observational measurement comparison study of 20,258 
consecutive patients and a decision analytic model was undertaken 
to determine the effectiveness and cost-effectiveness of three ARIA 
systems (Retmarker, iGRading, and EyeART) in replacing one or 
more steps of human grading in a NHS Diabetic Eye Screening 
Programme (DESP). Images were graded by human graders as well 
as the ARIA systems, before being sent for an arbitration, Secondary 
analysis explored the influence of patients’ ethnicity, age, sex and 
camera on screening performance.
Results: The sensitivity point estimates (95% confidence interval) 
of the ARIA systems are as follows: EyeArt 94.7% (94.2-95.2) for 
any retinopathy, 93.8% (92.9-94.6) for referable retinopathy 99.6% 
(97.0-99.9) for R3 proliferative retinopathy; Retmarker 73.0% 
(72.0-74.0) for any retinopathy, 85.0% (83.6-86.2) for referable 
retinopathy 97.9% (94.9-99.1) for R3 proliferative retinopathy. 
iGradingM classified all images as either having disease or being 
ungradeable, this limited further analyses for iGradingM. Both 
EyeArt and Retmarker are cost saving relative to manual grading 
either as a replacement for Level 1 human grading or as a filter prior 
to Level 1 human grading.
Conclusions: Retmarker and EyeArt achieved acceptable sensitivity 
for referable retinopathy when compared with a quality-assured, real 
world human grader working in a high volume clinical setting as a 
reference standard and had specificity sufficient to make them cost 
effective alternatives to a purely manual grading approach.
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